CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Planned sale SVP & General Counsel sold 2,958 shares at $7.57 ($22,392)
- 4 Planned sale SVP & Chief Compliance Officer sold 1,283 shares at $7.57 ($9,712)
- 4 Exercise or conversion SVP & CFO acquired 13,000 shares (option exercise)
- 4 Exercise or conversion SVP & General Counsel acquired 9,925 shares (option exercise)
- 4 Exercise or conversion SVP & Chief Compliance Officer acquired 4,300 shares (option exercise)
- 4 Planned sale SVP & CFO sold 5,479 shares at $9.79 ($53,639)
- 4 Exercise or conversion SVP & CFO acquired 18,625 shares (option exercise)
- 4 Planned sale SVP & Chief Compliance Officer sold 1,018 shares at $9.75 ($9,926)
- 4 Planned sale SVP & General Counsel sold 2,615 shares at $9.75 ($25,496)
- 4 Exercise or conversion SVP & Chief Compliance Officer acquired 3,456 shares (option exercise)
- 4 Exercise or conversion SVP & General Counsel acquired 8,886 shares (option exercise)
- 4 Planned sale SVP & CFO sold 6,498 shares at $10.19 ($66,215)
- 4 Planned sale SVP & General Counsel sold 4,380 shares at $10.19 ($44,632)
- 4 Planned sale SVP & Chief Compliance Officer sold 1,537 shares at $10.19 ($15,662)
- 4 Exercise or conversion SVP & CFO acquired 20,153 shares (option exercise)
- 4 Exercise or conversion SVP & General Counsel acquired 12,980 shares (option exercise)
- 4 Exercise or conversion SVP & Chief Compliance Officer acquired 4,375 shares (option exercise)
- 4 Planned sale President and CEO sold 28,786 shares at $9.10 ($261,953)
- 4 Exercise or conversion President and CEO acquired 93,750 shares (option exercise)
- 4 Planned sale SVP & CFO sold 10,733 shares at $10.53 ($113,018)
Page 3 of 13 · 251 filings